Before the first ballot was cast in the 2008, Obama's quest for health care reform caused havoc in the sector and among health care ETFs like iShares Nasdaq Biotechnology (IBB) and HOLDRS Merrill Lynch Pharmaceutical ETF (PPH).Government plans to extend health care to the uninsured and cut costs could certainly hinder major health care companies such as Amgen (AMGN) and Gilead (GILD), as lower costs cut into profits. Some analysts, however, believe that the influx of people into the heath care system and the bubble of aging baby boomers could make up for setbacks caused by reform.
Healthy Biotech and Pharma ETFs
Check Out Our Best Services for Investors
Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Every recommendation goes through 3 layers of intense scrutinyquantitative, fundamental and technical analysisto maximize profit potential and minimize risk.
More than 30 investing pros with skin in the game give you actionable insight and investment ideas.